CERTAIN INFORMATION HAS BEEN OMITTED FROM THIS DOCUMENT BECAUSE IT IS (I) NOT MATERIAL AND (II) WOULD BE COMPETITIVELY HARMFUL IF PUBLICLY DISCLOSED. OMISSIONS ARE MARKED [***] MANUFACTURING SERVICES AND LINE RETENTION AGREEMENTManufacturing Services and Line Retention Agreement • February 24th, 2023 • Insulet Corp • Surgical & medical instruments & apparatus
We appreciate very much for your choice of Flex Medical Sales and Marketing, Ltd., (“Flex”) as manufacturing partner of Insulet (“Customer”), in accordance with the terms and conditions of this Agreement.
INVENTIONS, NON-DISCLOSURE, NON-SOLICITATION, NON-SERVICING AND NON-COMPETITION AGREEMENTNon-Competition Agreement • February 24th, 2023 • Insulet Corp • Surgical & medical instruments & apparatus • Massachusetts
In consideration of my employment by Insulet Corporation, its successors, affiliates, parents, subsidiaries and subdivisions (collectively, the "Company") and the wages, benefits, training opportunities, and other terms and conditions of that employment, I hereby covenant and agree with the Company as follows:
AMENDMENT NUMBER 17 TO THE SUPPLY AGREEMENTThe Supply Agreement • February 24th, 2023 • Insulet Corp • Surgical & medical instruments & apparatus
This Amendment Number 17 ("Amendment''), entered into effective as of April 1, 2019 ("Amendment 17 Effective Date"), by and between Amgen Inc. ("Amgen") and lnsulet Corporation ("Insulet") amends the Agreement (defined below).
ContractAmendment and Restatement Agreement • February 24th, 2023 • Insulet Corp • Surgical & medical instruments & apparatus
THIS AMENDMENT AND RESTATEMENT AGREEMENT to the MASTER EQUIPMENT AND SERVICES AGREEMENT originally dated August 31, 2016 between lnsulet Corporation and ATS Automation Tooling Systems Inc., (the "MESA") is made and entered into as of 31 August 2021 by and between:
Insulet Corporation, Confidentiality, Non-Solicit, Non-Compete, and IP Assignment AgreementAssignment Agreement • February 24th, 2023 • Insulet Corp • Surgical & medical instruments & apparatus
This Confidentiality, Non-Solicit, Non-Compete, and IP Assignment Agreement (“Agreement”) is entered into between the undersigned individual (“I”, “me”, or “Employee”) and Insulet Corporation (collectively, the “Company”). I understand the Company is engaged in the business of designing, developing and marketing medical devices and related software (the Company’s “Business” or “Line of Business”). I understand that the Company seeks to employ me in a position of trust and confidence related to this Line of Business, and I wish to be employed in such a position. In consideration of my employment and the compensation and other benefits received as a consequence thereof, and the other mutual promises and representations of the parties made herein, the parties agree as follows:1
AMENDMENT NUMBER 18The Supply Agreement • February 24th, 2023 • Insulet Corp • Surgical & medical instruments & apparatus
This Amendment Number 18 ("Amendment"), entered into effective as of August 1, 2019 ("Amendment 18 Effective Date"), by and between Amgen Inc. ("Amgen") and Insulet Corporation ("Insulet") amends the Agreement (defined below).
MASTER EQUIPMENT AND SERVICES AGREEMENT AMENDMENT #2Master Equipment and Services Agreement • February 24th, 2023 • Insulet Corp • Surgical & medical instruments & apparatus
SERVICES AGREEMENT originally dated August 31, 2016 between Insulet Corporation and ATS Automation Tooling Systems Inc. as amended by the Amendment and Restatement Agreement dated August 31, 2021, (together, the “MESA”) is made and entered into as of 31 August 2022 by and between:
AMENDMENT NUMBER 20 TO THE SUPPLY AGREEMENTThe Supply Agreement • February 24th, 2023 • Insulet Corp • Surgical & medical instruments & apparatus
This Amendment Number 20 (“Amendment”), entered into effective as of June 25, 2021 (“Amendment 20 Effective Date”), by and between Amgen Inc. (“Amgen”) and Insulet Corporation (“Insulet”) amends the Agreement (defined below).
AMENDMENT NUMBER 15The Supply Agreement • February 24th, 2023 • Insulet Corp • Surgical & medical instruments & apparatus
This Amendment Number 15 ("Amendment"), entered into effective as of July 12, 2017 ("Amendment 15 Effective Date"), by and between Amgen Inc. ("Amgen") and Insulet Corporation ("Insulet") amends the Agreement (defined below).
